FDA 483 OBSERVATION · #71 OF 1,945 MOST-CITED

Specifications - components

FDA cited this observation 357 times across 347 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods357
BY FISCAL YEAR
FY20273
FY2026176
FY2025157
FY202421

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.7× the rate of the average FDA-cited firm (13.5% vs 7.8%), across 347 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications and limits on contamination to ensure the quality of the dietary supplement.

TopGum Pharma, Inc. · Copiague, New York · Foods · 2026-10-30

For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

Nature's Value Inc. · Coram, New York · Foods · 2026-10-15

For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

Nutralife Biosciences, Inc. · Coconut Creek, Florida · Foods · 2026-10-01

For component(s) used in the manufacture of a dietary supplement, you did not establish necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

Natural Solution Laboratories, Inc. · Gravette, Arkansas · Foods · 2026-09-22

For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

Remedy's Health Food, Inc. · Key Largo, Florida · Foods · 2026-09-22

For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

NCAQCO, LLC · Chesterfield, Missouri · Foods · 2026-09-18

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →